← SynDRA
PF-03049423
SynDRA canonical compound SYN0020505 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | PDE5A |
| Mechanism of action | phosphodiesterase inhibitor |
All known targets
Mechanisms of action (all sources)
- PDE5A INHIBITOR
- Phosphodiesterase 5A inhibitor
- phosphodiesterase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNH2
- HDAC6
- PDE1A
- PDE1B
- PDE1C
- PDE3A
- PDE3B
- PDE4A
- PDE4B
- PDE4C
- PDE4D
- PDE7B
- PDE8A
- PDE8B
Cross-references
Synonyms
- RefChem:928922
- PF-03049423 free base
- PF-5
- 9CZX3Z9945
- PF-03049423 (free base)
- starbld0047099
- UNII-9CZX3Z9945
- orb1685323
- SCHEMBL1969224
- SCHEMBL29357029
- SCHEMBL29766850
- MNLNAGRCHNMKKJ-UHFFFAOYSA-N
- BDBM50308557
- AKOS005766019
- GE-0036
- DA-56724
- DA-76751
- HY-10679
- CS-0002732
- T90611
- BRD-K07070922-001-01-4
- PF-03049423 hydrochloride
- T8B22PH792
- CRA95558
- UNII-T8B22PH792
Look up PF-03049423 in the interactive SynDRA portal →